[1] |
Zhang H,Kobayashi R,Galaktionov K, et al. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell, 1995, 82(6): 915-925.
|
[2] |
Hall PA,Levison DA,Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol, 1990, 162(4): 285-294.
|
[3] |
Slingerland J,Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol, 2000, 183(1): 10-17.
|
[4] |
Porter PL,Malone KE,Heagerty PJ, et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med, 1997, 3(2): 222-225.
|
[5] |
Signoretti S,Di Marcotullio L,Richardson A, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest, 2002, 110(5): 633-641.
|
[6] |
杨秉辉,夏景林.原发性肝癌的临床诊断与分期标准.中华肝脏病杂志, 2001, 9(6): 324.
|
[7] |
Sarmento LM,Huang H,Limon A, et al. Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med, 2005, 202(1): 157-168.
|
[8] |
Lin DI,Diehl JA. Mechanism of cell-cycle control: ligating the ligase. Trends Biochem Sci, 2004, 29(9): 453-455.
|
[9] |
Sistrunk C,Kim SH,Wang X, et al. Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27(Kip1) accumulation. Am J Patho, 2013, 182(5): 1854-1864.
|
[10] |
Luo Y,Xu DQ,Dong HY, et al. Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway. PLoS One, 2013, 8(2): e56774.
|
[11] |
Castagnino P,Kothapalli D,Hawthorne EA, et al. miR-221/222 compensates for Skp2-mediated p27 degradation and is a primary target of cell cycle regulation by prostacyclin and cAMP. PLoS One, 2013, 8(2):e56140.
|
[12] |
Wei Z,Jiang X,Liu F, et al. Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo. Tumour Biol, 2013, 34(1): 181-192.
|
[13] |
Pushpavalli S,Ramaiah MJ,Srinivas Ch, et al. Effect of benzothiazole based conjugates in causing apoptosis by regulating p53, PTEN and MAP kinase proteins affecting miR-195a and miR-101-1. Cancer Cell Int, 2011, 11: 36.
|
[14] |
Ebelt J,Neid M,Tannapfel A, et al. Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC). Zentralbl Chir(德文), 2000, 125(7): 597-601.
|
[15] |
陈兆雷,李君,王道荣,等.增殖细胞核抗原在肝移植后肝癌复发与转移中的意义.南京医科大学学报:自然科学版, 2007, 8(8):829-830.
|
[16] |
王洪海,任宁,张辉,等.联合检测VEGF、PD-ECGF和PCNA表达预测肝细胞癌术后复发及预后.中国临床医学, 2005, 12(3): 448-451.
|
[17] |
曹家庆,胡小云. PCNA与AFP在人肝癌组织中的表达及其预后意义.实用癌症杂志, 1998, 13(2): 105-107.
|
[18] |
Terada T,Nakanuma Y. Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma.an immunohistochemical study demonstrating proliferating cell nuclear antigen. Cancer, 1992, 70(3): 591-598.
|
[19] |
邵凤珍,施伯安,刘文全,等.天津地区家族聚集性慢性乙型肝炎病毒感染者病毒载量及组织病变与基因型的关系.中华肝脏病杂志, 2007, 15(1): 16-18.
|
[20] |
颜见,潘楚芝,姚志成,等.肝癌家族史对原发性肝癌患者手术治疗预后的影响.中华普通外科杂志, 2012, 27(10): 798-801.
|
[21] |
颜见,姚志成,钟跃思,等.第10号染色体缺失的磷酸酶及张力蛋白同源的基因在家族聚集性肝癌组织中的表达及临床意义.中华实验外科杂志, 2012, 29(10): 1892-1895.
|